SWQRX | VLXVX | SWQRX / VLXVX | |
Total Expense Ratio | 0.58 | 0.08 | 725% |
Annual Report Gross Expense Ratio | 0.92 | 0.08 | 1,150% |
Fund Existence | 4 years | 8 years | - |
Gain YTD | 9.855 | 10.173 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.6M | 11.4B | 0% |
Annual Yield % from dividends | 1.55 | 1.88 | 82% |
Returns for 1 year | 11.39 | 12.03 | 95% |
Returns for 3 years | 41.37 | 45.51 | 91% |
Returns for 5 years | N/A | 62.78 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NARCX | 65.45 | 0.56 | +0.86% |
Voya Multi-Manager International Sm Cp C | |||
DIEAX | 42.96 | 0.24 | +0.56% |
BNY Mellon International Core Equity A | |||
SCWCX | 58.69 | 0.24 | +0.41% |
American Funds SMALLCAP World C | |||
FBIOX | 18.30 | N/A | N/A |
Fidelity Select Biotechnology | |||
GSEUX | 68.43 | -0.19 | -0.28% |
Goldman Sachs US Equity Insights R6 |